SCHEMBL22889207

SCHEMBL22889207

c1ccc(-c2cccc3ccccc23)c(-c2nc(-c3ccc(-c4cc5ccccc5c5ccccc45)cc3)nc(-c3cccc4c3oc3ccccc34)n2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.45
ALDH1A1 P00352 7/20 0.37
HSD17B10 Q99714 6/20 0.37
KDM4E B2RXH2 6/20 0.37
HPGD P15428 5/20 0.37
MAPT P10636 5/20 0.37
GAA P10253 1/20 0.37
MAPK1 P28482 4/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
TSHR P16473 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
ATM Q13315 2/20 0.36
TP53 P04637 2/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CASP1 P29466 1/20 0.36
HIF1A Q16665 1/20 0.36
PRKDC P78527 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22889321 0.95 ALOX5 (0.45) ALOX5ALDH1A1HSD17B10KDM4EHPGD
SCHEMBL22888600 0.95 ALOX5 (0.47) ALOX5ALDH1A1HSD17B10KDM4EHPGD
SCHEMBL22889320 0.95 ALOX5 (0.47) ALOX5ALDH1A1HSD17B10KDM4EHPGD
SCHEMBL22889395 0.94 ALOX5 (0.50) ALOX5ALDH1A1HSD17B10KDM4EHPGD
SCHEMBL22888639 0.93 ALOX5 (0.43) ALOX5ALDH1A1HSD17B10KDM4EHPGD
SCHEMBL22888796 0.93 ALOX5 (0.44) ALOX5ALDH1A1HSD17B10KDM4EHPGD
SCHEMBL22889374 0.92 ALOX5 (0.44) ALOX5ALDH1A1HSD17B10KDM4EHPGD
SCHEMBL22889253 0.92 ALOX5 (0.46) ALOX5ALDH1A1HSD17B10KDM4EHPGD
SCHEMBL22888837 0.92 ALOX5 (0.46) ALOX5ALDH1A1HSD17B10KDM4EHPGD
SCHEMBL22889370 0.91 ALOX5 (0.47) ALOX5ALDH1A1HSD17B10KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO.,LTD. (JP) 2021-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OR10J3, RPS4Y1, AR ALOX5 3163/4885ALDH1A1 1387/4885HSD17B10 2902/4885
US-11765972-B2 Compound and organic electroluminescence device using the same AR, OR10J3, RPS4Y1 ALOX5 3071/4885ALDH1A1 1441/4885HSD17B10 2896/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.